You have no items in your shopping cart.
Search results for: 'VEGF'
Recombinant Mouse VEGF 164 [orb2993968]Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 19.27 KDa. Observed: 18-22 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Mouse VEGF-D (C-6His) [orb2994004]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13.1 KDa. Observed: 17-20 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Rat VEGF 164 [orb2994452]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 19.2 KDa. Observed: 18-23 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VEGFB (N-Fc) [orb2994163]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.7 KDa. Observed: 40&60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VEGF-D (C-6His) [orb2995034]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 13 KDa. Observed: 18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VEGF 121 [orb2994925]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.2 KDa. Observed: 16 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VEGF 121 (C-6His) [orb2994931]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1 KDa. Observed: 16-18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human VEGF-C (C-6His) [orb2995003]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.27 KDa. Observed: 25-30 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg